These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12527754)

  • 21. MgATP and fructose 6-phosphate interactions with phosphofructokinase from Escherichia coli.
    Johnson JL; Reinhart GD
    Biochemistry; 1992 Nov; 31(46):11510-8. PubMed ID: 1445885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-induced conformational transitions in Escherichia coli phosphofructokinase 2: evidence for an allosteric site for MgATP2-.
    Guixé V; Rodríguez PH; Babul J
    Biochemistry; 1998 Sep; 37(38):13269-75. PubMed ID: 9748334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folding kinetic pathway of phosphofructokinase-2 from Escherichia coli: a homodimeric enzyme with a complex domain organization.
    Baez M; Wilson CA; Babul J
    FEBS Lett; 2011 Jul; 585(14):2158-64. PubMed ID: 21627967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fructose-6-phosphate modifies the pathway of the urea-induced dissociation of the allosteric phosphofructokinase from Escherichia coli.
    Teschner W; Deville-Bonne D; Garel JR
    FEBS Lett; 1990 Jul; 267(1):96-8. PubMed ID: 2142107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
    Trapani S; Linss J; Goldenberg S; Fischer H; Craievich AF; Oliva G
    J Mol Biol; 2001 Nov; 313(5):1059-72. PubMed ID: 11700062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid substitution in the active site of Escherichia coli aspartate transcarbamoylase prevents the allosteric transition.
    Stieglitz KA; Pastra-Landis SC; Xia J; Tsuruta H; Kantrowitz ER
    J Mol Biol; 2005 Jun; 349(2):413-23. PubMed ID: 15890205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of cross-linked rabbit muscle phosphofructokinase in solution.
    Paradies HH
    J Biol Chem; 1979 Aug; 254(16):7495-504. PubMed ID: 157353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of a two-state model to describe the influence of phospho(enol)pyruvate on phosphofructokinase from Escherichia coli.
    Johnson JL; Reinhart GD
    Biochemistry; 1997 Oct; 36(42):12814-22. PubMed ID: 9335538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MgATP-dependent activation by phosphoenolpyruvate of the E187A mutant of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    Biochemistry; 2001 Apr; 40(13):4150-8. PubMed ID: 11300796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition.
    Mattevi A; Valentini G; Rizzi M; Speranza ML; Bolognesi M; Coda A
    Structure; 1995 Jul; 3(7):729-41. PubMed ID: 8591049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of MgADP on phosphofructokinase from Escherichia coli. Elucidation of coupling interactions with both substrates.
    Johnson JL; Reinhart GD
    Biochemistry; 1994 Mar; 33(9):2635-43. PubMed ID: 8117726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale domain movements and hydration structure changes in the active-site cleft of unligated glutamate dehydrogenase from Thermococcus profundus studied by cryogenic X-ray crystal structure analysis and small-angle X-ray scattering.
    Nakasako M; Fujisawa T; Adachi S; Kudo T; Higuchi S
    Biochemistry; 2001 Mar; 40(10):3069-79. PubMed ID: 11258921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific structure/function differentiation of the liver isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Lee YH; Li Y; Uyeda K; Hasemann CA
    J Biol Chem; 2003 Jan; 278(1):523-30. PubMed ID: 12379646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Small-angle scattering of the quaternary structure of phosphofructokinase from baker's yeast].
    Plietz P; Damaschun G; Kopperschläger G; Müller JJ
    Acta Biol Med Ger; 1978; 37(4):513-7. PubMed ID: 153693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory properties of phosphofructokinase 2 from Escherichia coli.
    Kotlarz D; Buc H
    Eur J Biochem; 1981 Jul; 117(3):569-74. PubMed ID: 6456900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of the phosphofructokinase from Lactobacillus bulgaricus. A non-allosteric analog of the enzyme from Escherichia coli.
    Le Bras G; Deville-Bonne D; Garel JR
    Eur J Biochem; 1991 Jun; 198(3):683-7. PubMed ID: 1828763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of substrate inhibition in Escherichia coli phosphofructokinase.
    Fenton AW; Reinhart GD
    Biochemistry; 2003 Nov; 42(43):12676-81. PubMed ID: 14580215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.
    Mariani P; Carsughi F; Spinozzi F; Romanzetti S; Meier G; Casadio R; Bergamini CM
    Biophys J; 2000 Jun; 78(6):3240-51. PubMed ID: 10828000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.